Platelet-Rich Plasma (PRP) and Recombinant Growth Factor Therapies in Cutaneous Wound Healing: Mechanisms, Clinical Applications, and Future Directions
Journal of Clinical Medicine · 03.12.2025 · 14 (23) · 8583
DOI: 10.3390/jcm14238583 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.12.2025. Verfasst von Abu-Bakr Ahmed und 7 weiteren Autor:innen. Beteiligte Einrichtung: Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV 89106, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kirk Kerkorian School of Medicine at the University of Nevada.
Themen: Wundversorgung
Abstract (Originalsprache)
Background
Chronic cutaneous wounds such as diabetic foot ulcers, venous leg ulcers, pressure injuries, and burns remain a global clinical burden. These wounds are often arrested in inflammatory or ischemic stages due to impaired angiogenesis and growth factor deficiencies. Biologic therapies, such as platelet-rich plasma (PRP) and recombinant growth factors, aim to restore these deficits and accelerate repair.
Methods
A narrative review of PubMed and Google Scholar (2015–2025) identified 64 English-language studies, including randomized controlled trials, meta-analyses, and translational investigations evaluating PRP and recombinant growth factors in wound healing.
Results
Randomized trials and meta-analyses show that adjunctive autologous PRP increases complete wound closure versus standard care in chronic ulcers, including diabetic foot and venous leg ulcers (odds ratios ≈ 2–8), and improves healing rates in pressure injuries (odds ratio ≈ 3.4), without increasing adverse events. In diabetic foot ulcers, PDGF-BB and EGF, together with PRP, consistently improve complete healing and reduce ulcer area. In burns, topical EGF and bFGF shorten healing time by ~3 days in superficial partial-thickness wounds and by >5 days in deeper burns, with generally improved scar outcomes.
Conclusions
PRP offers broad, autologous biologic activation, while recombinant growth factors deliver high-potency, targeted precision. Together, they represent complementary regenerative strategies that can shorten healing times and improve outcomes in chronic wounds. Standardized multicenter trials quantifying cytokine composition, cost-effectiveness, and long-term limb-salvage benefit are warranted to guide their integration into routine clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV 89106, USA.
- Lake Erie College of Osteopathic Medicine, Elmira, NY 14901, USA.
- School of Integrated Health Sciences, University of Nevada, Las Vegas, Las Vegas, NV 89106, USA.
- Department of Medical Education, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV 89106, USA.
ORCID-Profile: Abu-Bakr Ahmed, Joshua Khorsandi, Michael Lee, Adam Jaouhari, Aftab Merchant
Förderung
- Kirk Kerkorian School of Medicine at the University of Nevada
Zitieren
APA
Ahmed, A. B., Thatcher, S., Khorsandi, J., Ahmed, Z., Lee, M., Jaouhari, A., Bond, B., & Merchant, A. (2025). Platelet-Rich Plasma (PRP) and Recombinant Growth Factor Therapies in Cutaneous Wound Healing: Mechanisms, Clinical Applications, and Future Directions. Journal of Clinical Medicine, 14(23), 8583. https://doi.org/10.3390/jcm14238583
Vancouver
Ahmed AB, Thatcher S, Khorsandi J, Ahmed Z, Lee M, Jaouhari A, et al. Platelet-Rich Plasma (PRP) and Recombinant Growth Factor Therapies in Cutaneous Wound Healing: Mechanisms, Clinical Applications, and Future Directions. Journal of Clinical Medicine. 2025;14(23):8583. doi:10.3390/jcm14238583
BibTeX
@article{Ahmed2025,
author = {Ahmed, Abu-Bakr and Thatcher, Spencer and Khorsandi, Joshua and Ahmed, Zahra and Lee, Michael and Jaouhari, Adam and Bond, Braydon and Merchant, Aftab},
title = {Platelet-Rich Plasma (PRP) and Recombinant Growth Factor Therapies in Cutaneous Wound Healing: Mechanisms, Clinical Applications, and Future Directions},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {23},
pages = {8583},
doi = {10.3390/jcm14238583}
}
EUVIMED